Aconitum Napellus Fear Pills Recalled for Failed Quality Testing
Washington Homeopathic Products is recalling Aconitum Napellus Fear homeopathic pills in multiple potencies and package sizes (562 bottles, Lot #26198) distributed nationwide because test results showed out-of-specification identification results on HPTLC analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a quality/identification failure detected through testing rather than a direct safety threat to consumers. The recall appears to be precautionary in nature based on failed analytical testing.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Aconitum Napellus Fear sucrose/lactose pills in multiple potencies (6X, 7X, 8X, 9X, 10X, 12X, 15X, 16X, 18X, 24X, and 30X) and package sizes (1 oz, 2 dram, 2 oz, and 4 dram containers). A total of 562 bottles from Lot #26198 have been distributed nationwide in the USA.
The recall is due to out-of-specification test results obtained during identification testing using HPTLC (high-performance thin-layer chromatography) analysis. This testing failure indicates that the product does not meet established quality and identification specifications.
Consumers who have purchased this product should stop using it and discard it. Healthcare professionals and consumers with questions about this recall may contact Washington Homeopathic Products, Inc. at their address in Berkeley Springs, West Virginia.
The recalled product
- Product
- Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 8X, 9X, 12X,30X, packaged in 1 oz containers, Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 6X, 10X, 15X, 24X, 30X, packaged in 2 dr containers, Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 6X, 30X, packaged in 2 oz
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- quality-control-failure
- failed-identification-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 26198
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27